Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Central Garden & Pet Announces Q3 Fiscal 2024 Financial Results


Central Garden Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) (“Central”), a market leader in the Pet and Garden industries, today announced financial results for its fiscal 2024 third quarter ended June 29, 2024.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240807439810/en/

"We delivered a solid third quarter earnings performance, recognizing that we had a record third quarter in 2023," said Beth Springer, Interim CEO. "Our Cost and Simplicity program continues to prove effective as evidenced in our improved gross margins. Looking ahead, we remain committed to our long-term Central to Home strategy."

Fiscal 2024 Third Quarter Financial Results

Net sales were $996 million compared to $1,023 million a year ago, a decrease of 3%. Organic net sales also decreased 3%.

Gross profit was $317 million compared to $318 million a year ago. Non-GAAP gross profit of $326 million was in line with the prior year. Gross margin expanded by 70 basis points to 31.8%. On a non-GAAP basis, gross margin expanded by 80 basis points to 32.7% driven by Central's Cost and Simplicity program and moderating inflation.

Operating income was $116 million compared to $123 million a year ago, a decrease of 6%. Non-GAAP operating income was $127 million compared to $137 million in the prior year. Operating margin was 11.6% compared to 12.0% a year ago. On a non-GAAP basis, operating margin was 12.8% compared to 13.4% in the prior year.

Net interest expense was $10 million compared to $13 million a year ago.

Net income was $80 million compared to $83 million in the prior year, a decrease of 4%. Non-GAAP net income was $88 million compared to $94 million a year ago. Earnings per share were $1.19 compared to $1.25 in the prior year, a decrease of $0.06. Non-GAAP earnings per share were $1.32 compared to $1.40 a year ago. Adjusted EBITDA was $156 million compared to $166 million a year ago.

The effective tax rate was 24.0% compared to 24.4% in the prior year.

Pet Segment Fiscal 2024 Third Quarter Results

Net sales for the Pet segment were $508 million compared to $503 million in the prior year, an increase of 1% driven by the recent TDBBS acquisition and growth in consumable pet products. Organic net sales decreased 2% excluding the impact of TDBBS.

Pet segment operating income was $83 million compared to $60 million a year ago, an increase of 39%. Operating margin expanded by 450 basis points to 16.4% compared to 11.9% driven by improved gross margin. Pet segment adjusted EBITDA was $94 million compared to $84 million in the prior year.

Garden Segment Fiscal 2024 Third Quarter Results

Net sales for the Garden segment were $488 million compared to $520 million a year ago, a decrease of 6%. Organic net sales decreased 4% excluding the impact of the sale of the independent garden channel distribution business.

Garden segment operating income was $63 million compared to $88 million in the prior year, a decrease of 29%. Non-GAAP operating income was $74 million. Operating margin contracted 410 basis points to 12.8% compared to 16.9%. On a non-GAAP basis, operating margin contracted 180 basis points to 15.1% driven by lower sell through in live plants. Garden segment adjusted EBITDA was $85 million compared to $99 million a year ago.

Liquidity and Debt

The cash balance at the end of the quarter was $570 million compared to $333 million a year ago driven by earnings and inventory reduction efforts over the last 12 months.

Cash provided by operations during the quarter was $286 million compared to $325 million a year ago.

Total debt as of June 29, 2024, and June 24, 2023 was $1.2 billion. The gross leverage ratio, as defined in Central's credit agreement, at the end of the third quarter was 3.0x compared to 3.1x at the end of the prior year quarter.

Cost and Simplicity Program

Central continues to advance its multi-year Cost and Simplicity program consisting of a pipeline of projects across procurement, manufacturing, logistics, portfolio management and administrative costs to simplify its business and improve efficiency across the organization.

In the third quarter of fiscal 2024, Central began winding down its pottery business.

As a result of Cost and Simplicity projects, Central incurred $11.1 million of one-time costs largely related to the pottery exit, including $8.6 million in cost of goods sold and $2.5 million in selling, general and administrative costs, the majority of which was non-cash.

Fiscal 2024 Guidance

Central continues to expect fiscal 2024 non-GAAP EPS to be $2.00 or better ($2.50 or better before the February 2024 stock dividend) despite currently anticipating a one-time charge in the range of $15-20 million in the fourth quarter. Given the recent significant decrease in market prices for grass seed, Central determined in August 2024 it will be necessary to write down the value of its grass seed inventory.

This outlook reflects uncertain consumer demand and retailer dynamics and an environment of macroeconomic and geopolitical volatility. It excludes the impact of any restructuring activities that may occur during the fourth quarter of fiscal 2024, including projects under the Cost and Simplicity program or other one-time non-recurring charges. Central now expects fiscal 2024 capital spending to be approximately $60 million.

Conference Call

Central's senior management will hold a conference call today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its fiscal 2024 third quarter results and provide a general business update. The conference call and related materials can be accessed at http://ir.central.com.

Alternatively, to listen to the call by telephone, dial (201) 689-8345 (domestic and international) using confirmation #13746730.

About Central Garden Pet

Central Garden Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) understands home is central to life and has proudly nurtured happy and healthy homes for over 40 years. With fiscal 2023 net sales of $3.3 billion, Central is on a mission to lead the future of the Pet and Garden industries. The Company’s innovative and trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier, and communities grow stronger. Central is home to a leading portfolio of more than 65 high-quality brands including Amdro®, Aqueon®, Cadet®, Farnam®, Ferry-Morse®, Four Paws®, Kaytee®, K®, Nylabone® and Pennington®, strong manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central is based in Walnut Creek, California, with 6,700 employees primarily across North America. Visit www.central.com to learn more.

Safe Harbor Statement

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release which are not historical facts, including statements concerning evolving consumer demand and unfavorable retailer dynamics, the carryover impact from pricing actions, productivity initiatives and estimated capital spending, anticipated inventory write-down, and earnings guidance for fiscal 2024, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. All forward-looking statements are based upon Central's current expectations and various assumptions. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release including, but not limited to, the following factors:

  • impact of inflation and interest rates, and other adverse macro-economic conditions;
  • fluctuations in market prices for seeds and grains and other raw materials, including the impact of the recent significant decline in grass seed market prices on our inventory valuation;
  • our inability to pass through cost increases in a timely manner;
  • our ability to recruit and retain members of our management team and employees, including a Chief Executive Officer, to support our businesses;
  • fluctuations in energy prices, fuel and related petrochemical costs;
  • declines in consumer spending and increased inventory risk during economic downturns;
  • reductions in demand for product categories that benefited from the COVID-19 pandemic;
  • adverse weather conditions;
  • the success of our Central to Home strategy and our Cost and Simplicity program;
  • risks associated with our acquisition strategy, including our ability to successfully integrate acquisitions and the impact of purchase accounting on our financial results;
  • material weaknesses relating to the internal controls of recently acquired companies;
  • seasonality and fluctuations in our operating results and cash flow;
  • supply shortages in pet birds, small animals and fish;
  • dependence on a small number of customers for a significant portion of our business;
  • consolidation trends in the retail industry;
  • risks associated with new product introductions, including the risk that our new products will not produce sufficient sales to recoup our investment;
  • competition in our industries;
  • continuing implementation of an enterprise resource planning information technology system;
  • potential environmental liabilities;
  • risks associated with international sourcing;
  • impacts of tariffs or a trade war;
  • access to and cost of additional capital;
  • potential goodwill or intangible asset impairment;
  • our ability to remediate material weaknesses in our internal control over financial reporting;
  • our dependence upon our key executives;
  • our ability to protect our trademarks and other proprietary rights;
  • litigation and product liability claims;
  • regulatory issues;
  • the impact of product recalls;
  • potential costs and risks associated with actual or potential cyberattacks;
  • potential dilution from issuance of authorized shares;
  • the voting power associated with our Class B stock; and
  • the impact of new accounting regulations and the possibility our effective tax rate will increase as a result of future changes in the corporate tax rate or other tax law changes.

These risks and others are described in Central’s Securities and Exchange Commission filings. Central undertakes no obligation to publicly update these forward-looking statements to reflect new information, subsequent events or otherwise. Central has not filed its Form 10-Q for the fiscal quarter ended June 29, 2024, so all financial results are preliminary and subject to change.

CENTRAL GARDEN PET COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts, unaudited)

 

 

June 29, 2024

 

June 24, 2023

 

September 30, 2023

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

570,398

 

 

$

333,139

 

 

$

488,730

 

Restricted cash

 

13,980

 

 

 

13,542

 

 

 

14,143

 

Accounts receivable (less allowance for credit losses and customer allowances of $24,838, $29,245 and $25,797)

 

507,524

 

 

 

492,850

 

 

 

332,890

 

Inventories, net

 

784,775

 

 

 

865,496

 

 

 

838,188

 

Prepaid expenses and other

 

33,493

 

 

 

36,655

 

 

 

33,172

 

Total current assets

 

1,910,170

 

 

 

1,741,682

 

 

 

1,707,123

 

Plant, property and equipment, net

 

384,373

 

 

 

392,332

 

 

 

391,768

 

Goodwill

 

546,436

 

 

 

546,436

 

 

 

546,436

 

Other intangible assets, net

 

472,854

 

 

 

512,175

 

 

 

497,228

 

Operating lease right-of-use assets

 

188,506

 

 

 

172,379

 

 

 

173,540

 

Other assets

 

105,539

 

 

 

54,943

 

 

 

62,553

 

Total

$

3,607,878

 

 

$

3,419,947

 

 

$

3,378,648

 

LIABILITIES AND EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

$

191,041

 

 

$

198,406

 

 

$

190,902

 

Accrued expenses

 

276,751

 

 

 

247,517

 

 

 

216,241

 

Current lease liabilities

 

53,363

 

 

 

50,209

 

 

 

50,597

 

Current portion of long-term debt

 

290

 

 

 

255

 

 

 

247

 

Total current liabilities

 

521,445

 

 

 

496,387

 

 

 

457,987

 

Long-term debt

 

1,189,366

 

 

 

1,187,498

 

 

 

1,187,956

 

Long-term lease liabilities

 

151,038

 

 

 

132,419

 

 

 

135,621

 

Deferred income taxes and other long-term obligations

 

150,249

 

 

 

156,537

 

 

 

144,271

 

Equity:

 

 

 

 

 

Common stock, $0.01 par value: 11,077,612, 11,098,584 and 11,077,612 shares outstanding at June 29, 2024, June 24, 2023 and September 30, 2023

 

111

 

 

 

111

 

 

 

111

 

Class A common stock, $0.01 par value: 54,719,533, 54,408,159 and 54,472,902 shares outstanding at June 29, 2024, June 24, 2023 and September 30, 2023

 

547

 

 

 

544

 

 

 

544

 

Class B stock, $0.01 par value: 1,602,374 shares outstanding at June 29, 2024, June 24, 2023 and September 30, 2023

 

16

 

 

 

16

 

 

 

16

 

Additional paid-in capital

 

595,646

 

 

 

588,597

 

 

 

594,282

 

Retained earnings

 

1,000,527

 

 

 

858,217

 

 

 

859,370

 

Accumulated other comprehensive loss

 

(3,199

)

 

 

(1,955

)

 

 

(2,970

)

Total Central Garden Pet Company shareholders’ equity

 

1,593,648

 

 

 

1,445,530

 

 

 

1,451,353

 

Noncontrolling interest

 

2,132

 

 

 

1,576

 

 

 

1,460

 

Total equity

 

1,595,780

 

 

 

1,447,106

 

 

 

1,452,813

 

Total

$

3,607,878

 

 

$

3,419,947

 

 

$

3,378,648

 

CENTRAL GARDEN PET COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts, unaudited)

 

 

Three Months Ended

 

Nine Months Ended

 

June 29, 2024

 

June 24, 2023

 

June 29, 2024

 

June 24, 2023

Net sales

$

996,348

 

 

$

1,023,269

 

 

$

2,530,971

 

 

$

2,559,936

 

Cost of goods sold

 

679,290

 

 

 

705,217

 

 

 

1,756,188

 

 

 

1,810,547

 

Gross profit

 

317,058

 

 

 

318,052

 

 

 

774,783

 

 

 

749,389

 

Selling, general and administrative expenses

 

201,122

 

 

 

195,222

 

 

 

556,988

 

 

 

548,112

 

Operating income

 

115,936

 

 

 

122,830

 

 

 

217,795

 

 

 

201,277

 

Interest expense

 

(14,720

)

 

 

(14,542

)

 

 

(43,412

)

 

 

(43,887

)

Interest income

 

4,504

 

 

 

1,408

 

 

 

12,016

 

 

 

2,287

 

Other income

 

225

 

 

 

853

 

 

 

1,047

 

 

 

3,147

 

Income before Income taxes and noncontrolling interest

 

105,945

 

 

 

110,549

 

 

 

187,446

 

 

 

162,824

 

Income tax expense

 

25,468

 

 

 

27,000

 

 

 

43,733

 

 

 

39,446

 

Income including noncontrolling interest

 

80,477

 

 

 

83,549

 

 

 

143,713

 

 

 

123,378

 

Net income attributable to noncontrolling interest

 

753

 

 

 

423

 

 

 

1,572

 

 

 

570

 

Net income attributable to Central Garden Pet Company

$

79,724

 

 

$

83,126

 

 

$

142,141

 

 

$

122,808

 

Net income per share attributable to Central Garden Pet Company:

 

 

 

 

 

 

 

Basic

$

1.21

 

 

$

1.27

 

 

$

2.17

 

 

$

1.87

 

Diluted

$

1.19

 

 

$

1.25

 

 

$

2.13

 

 

$

1.84

 

Weighted average shares used in the computation of net income per share:

 

 

 

 

 

 

 

Basic

 

65,850

 

 

 

65,580

 

 

 

65,636

 

 

 

65,577

 

Diluted

 

66,945

 

 

 

66,725

 

 

 

66,848

 

 

 

66,832

 

CENTRAL GARDEN PET COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)

 

 

Nine Months Ended

 

June 29, 2024

 

June 24, 2023

Cash flows from operating activities:

 

 

 

Net income

$

143,713

 

 

$

123,378

 

Adjustments to reconcile net income to net cash used by operating activities:

 

 

 

Depreciation and amortization

 

68,069

 

 

 

65,504

 

Amortization of deferred financing costs

 

2,013

 

 

 

2,023

 

Non-cash lease expense

 

39,183

 

 

 

38,180

 

Stock-based compensation

 

15,138

 

 

 

20,632

 

Deferred income taxes

 

3,622

 

 

 

9,125

 

Facility closures and business exit costs

 

16,385

 

 

 

13,923

 

Other operating activities

 

3,531

 

 

 

(450

)

Change in assets and liabilities (excluding businesses acquired):

 

 

 

Accounts receivable

 

(169,867

)

 

 

(115,358

)

Inventories

 

58,705

 

 

 

69,610

 

Prepaid expenses and other assets

 

(383

)

 

 

6,530

 

Accounts payable

 

(2,968

)

 

 

(12,248

)

Accrued expenses

 

51,213

 

 

 

44,221

 

Other long-term obligations

 

2,352

 

 

 

(55

)

Operating lease liabilities

 

(38,902

)

 

 

(37,449

)

Net cash provided by operating activities

 

191,804

 

 

 

227,566

 

Cash flows from investing activities:

 

 

 

Additions to plant, property and equipment

 

(33,096

)

 

 

(40,850

)

Payments to acquire companies, net of cash acquired

 

(59,818

)

 

 

 

Investments

 

(1,500

)

 

 

(500

)

Other investing activities

 

(175

)

 

 

(100

)

Net cash used in investing activities

 

(94,589

)

 

 

(41,450

)

Cash flows from financing activities:

 

 

 

Repayments of long-term debt

 

(289

)

 

 

(223

)

Borrowings under revolving line of credit

 

 

 

 

48,000

 

Repayments under revolving line of credit

 

 

 

 

(48,000

)

Repurchase of common stock, including shares surrendered for tax withholding

 

(14,755

)

 

 

(33,409

)

Payment of contingent consideration liability

 

(63

)

 

 

(33

)

Distribution to noncontrolling interest

 

(900

)

 

 

 

Net cash used by financing activities

 

(16,007

)

 

 

(33,665

)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

297

 

 

 

2,046

 

Net increase in cash, cash equivalents and restricted cash

 

81,505

 

 

 

154,497

 

Cash, cash equivalents and restricted cash at beginning of period

 

502,873

 

 

 

192,184

 

Cash, cash equivalents and restricted cash at end of period

$

584,378

 

 

$

346,681

 

Supplemental information:

 

 

 

Cash paid for interest

$

48,853

 

 

$

49,419

 

Cash paid for income taxes

$

38,027

 

 

$

5,363

 

New operating lease right of use assets

$

56,849

 

 

$

25,424

 

Use of Non-GAAP Financial Measures

We report our financial results in accordance with GAAP. However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including non-GAAP net income and diluted net income per share, non-GAAP operating income, adjusted EBITDA and organic net sales. Management uses these non-GAAP financial measures that exclude the impact of specific items (described below) in making financial, operating and planning decisions and in evaluating our performance. Also, Management believes that these non-GAAP financial measures may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods. While Management believes that non-GAAP measures are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.

Adjusted EBITDA is defined by us as income before income tax, net other expense, net interest expense and depreciation and amortization and stock-based compensation expense (or operating income plus depreciation and amortization expense and stock-based compensation expense). Adjusted EBITDA further excludes one-time charges related to facility closures. We present adjusted EBITDA because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluations. Adjusted EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP. We believe that adjusted EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results. Other companies may calculate adjusted EBITDA differently and it may not be comparable.

The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below.

Non-GAAP financial measures reflect adjustments based on the following items:

  • Facility closures and business exit: we have excluded the charges related to our decision to exit the pottery business and the closure of distribution and manufacturing facilities as they represent infrequent transactions that impact the comparability between operating periods. They exclude the impact of the expenditures related to the Cost and Simplicity program we have embarked on to improve our future operations. We believe these exclusions supplement the GAAP information with a measure that may be useful to investors in assessing the sustainability of our operating performance.

From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful supplemental information to investors and management.

  1. During the third quarter of fiscal 2024, we recognized incremental expense of $11.1 million in the consolidated statement of operations, from the decision to exit the pottery business, the closure of a live goods distribution facility in Delaware and the relocation of our grass seed research facility.
  2. During the second quarter of fiscal 2024, we recognized incremental expense of $5.3 million in the consolidated statement of operations, from the closure of a manufacturing facility in Chico, California and the consolidation of our Southeast distribution network.
  3. During the third quarter of fiscal 2023, we recognized incremental expense of $13.9 million in the consolidated statement of operations, from the closure of a leased manufacturing and distribution pet bedding facility in Athens, Texas.

Net Income and Diluted Net Income Per Share Reconciliation

 

GAAP to Non-GAAP
Reconciliation
Three Months Ended

 

GAAP to Non-GAAP
Reconciliation
Nine Months Ended

 

 

June 29, 2024

 

June 24, 2023

 

June 29, 2024

 

June 24, 2023

 

 

(in thousands, except per share amounts)

GAAP net income attributable to Central Garden Pet Company

 

$

79,724

 

 

$

83,126

 

 

$

142,141

 

 

$

122,808

 

Facility closures business exit

(1)

 

11,115

 

(3)

 

13,921

 

(1) (2)

 

16,385

 

(3)

 

13,921

 

Tax effect of facility closures business exit

 

 

(2,590

)

 

 

(3,373

)

 

 

(3,823

)

 

 

(3,373

)

Non-GAAP net income attributable to Central Garden Pet Company

 

$

88,249

 

 

$

93,674

 

 

$

154,703

 

 

$

133,356

 

GAAP diluted net income per share

 

$

1.19

 

 

$

1.25

 

 

$

2.13

 

 

$

1.84

 

Non-GAAP diluted net income per share

 

$

1.32

 

 

$

1.40

 

 

$

2.31

 

 

$

2.00

 

Shares used in GAAP and non-GAAP diluted net earnings per share calculation

 

 

66,945

 

 

 

66,725

 

 

 

66,848

 

 

 

66,832

 

Operating Income Reconciliation

 

GAAP to Non-GAAP Reconciliation

 

 

Three Months Ended June 29, 2024

 

Nine Months Ended June 29, 2024

 

 

GAAP

Facility Closure
Business
Exit (1)(2)

Non-GAAP

 

GAAP

Facility Closure
Business
Exit (1)(2)

Non-GAAP

 

 

(in thousands)

Net sales

 

$

996,348

$

 

$

996,348

 

$

2,530,971

$

 

$

2,530,971

Cost of goods sold and occupancy

 

 

679,290

 

8,613

 

 

670,677

 

 

1,756,188

 

11,140

 

 

1,745,048

Gross profit

 

$

317,058

$

(8,613

)

$

325,671

 

$

774,783

$

(11,140

)

$

785,923

Selling, general and administrative expenses

 

 

201,122

 

2,502

 

 

198,620

 

 

556,988

 

5,245

 

 

551,743

Income from operations

 

$

115,936

$

(11,115

)

$

127,051

 

$

217,795

$

(16,385

)

$

234,180

Operating Income Reconciliation

 

GAAP to Non-GAAP Reconciliation

 

 

Three Months Ended June 24, 2023

 

Nine Months Ended June 24, 2023

 

 

GAAP

Facility
closure (3)

Non-GAAP

 

GAAP

Facility
closure (3)

Non-GAAP

 

 

(in thousands)

Net sales

 

$

1,023,269

$

 

$

1,023,269

 

$

2,559,936

$

 

$

2,559,936

Cost of goods sold and occupancy

 

 

705,217

 

8,010

 

 

697,207

 

 

1,810,547

 

8,010

 

 

1,802,537

Gross profit

 

$

318,052

$

(8,010

)

$

326,062

 

$

749,389

$

(8,010

)

$

757,399

Selling, general and administrative expenses

 

 

195,222

 

5,911

 

 

189,311

 

 

548,112

 

5,911

 

 

542,201

Income from operations

 

$

122,830

$

(13,921

)

$

136,751

 

$

201,277

$

(13,921

)

$

215,198

Pet Segment Operating Income Reconciliation

 

GAAP to Non-GAAP Reconciliation
Three Months Ended

 

GAAP to Non-GAAP Reconciliation
Nine Months Ended

 

 

June 29, 2024

 

June 24, 2023

 

June 29, 2024

 

June 24, 2023

 

 

(in thousands)

GAAP operating income

 

$

83,068

 

 

$

59,969

 

 

$

189,115

 

 

$

154,779

 

Facility closure

(3)

 

 

 

 

13,921

 

 

 

 

 

 

13,921

 

Non-GAAP operating income

 

$

83,068

 

 

$

73,890

 

 

$

189,115

 

 

$

168,700

 

GAAP operating margin

 

 

16.4

%

 

 

11.9

%

 

 

13.5

%

 

 

11.1

%

Non-GAAP operating margin

 

 

16.4

%

 

 

14.7

%

 

 

13.5

%

 

 

12.1

%

Garden Segment Operating Income Reconciliation

 

GAAP to Non-GAAP Reconciliation
Three Months Ended

 

GAAP to Non-GAAP Reconciliation
Nine Months Ended

 

 

June 29, 2024

 

June 24, 2023

 

June 29, 2024

 

June 24, 2023

 

 

(in thousands)

GAAP operating income

 

$

62,519

 

 

$

88,088

 

 

$

110,699

 

 

$

126,887

 

Facility closure business exit

(1)

 

11,115

 

 

 

 

(1) (2)

 

16,385

 

 

 

 

Non-GAAP operating income

 

$

73,634

 

 

$

88,088

 

 

$

127,084

 

 

$

126,887

 

GAAP operating margin

 

 

12.8

%

 

 

16.9

%

 

 

9.8

%

 

 

10.9

%

Non-GAAP operating margin

 

 

15.1

%

 

 

16.9

%

 

 

11.2

%

 

 

10.9

%

Organic Net Sales Reconciliation

 

GAAP to Non-GAAP Reconciliation

 

 

Three Months Ended June 29, 2024

 

Nine Months Ended June 29, 2024

 

 

Net sales
(GAAP)

 

Effect of
acquisitions
divestitures on
net sales

 

Net sales
organic

 

Net sales
(GAAP)

 

Effect of
acquisitions
divestitures on
net sales

 

Net sales
organic

 

 

(in millions)

Q3 FY 24

 

$

996.3

 

 

$

15.8

 

$

980.5

 

 

$

2,531.0

 

 

$

48.4

 

$

2,482.6

 

Q3 FY 23

 

 

1,023.3

 

 

 

13.0

 

 

1,010.3

 

 

 

2,559.9

 

 

 

44.4

 

 

2,515.5

 

$ decrease

 

$

(27.0

)

 

 

 

$

(29.8

)

 

$

(28.9

)

 

 

 

$

(32.9

)

% decrease

 

 

(2.6

)%

 

 

 

 

(2.9

)%

 

 

(1.1

)%

 

 

 

 

(1.3

)%

Organic Pet Segment Net Sales Reconciliation

 

GAAP to Non-GAAP Reconciliation

 

 

Three Months Ended June 29, 2024

 

Nine Months Ended June 29, 2024

 

 

Net sales
(GAAP)

 

Effect of
acquisitions
divestitures on
net sales

 

Net sales
organic

 

Net sales
(GAAP)

 

Effect of
acquisitions
divestitures on
net sales

 

Net sales
organic

 

 

(in millions)

Q3 FY 24

 

$

508.0

 

 

$

15.8

 

$

492.2

 

 

$

1,397.5

 

 

$

48.4

 

$

1,349.1

 

Q3 FY 23

 

 

503.3

 

 

 

 

 

503.3

 

 

 

1,394.3

 

 

 

 

 

1,394.3

 

$ increase (decrease)

 

$

4.7

 

 

 

 

$

(11.1

)

 

$

3.2

 

 

 

 

$

(45.2

)

% increase (decrease)

 

 

0.9

%

 

 

 

 

(2.2

)%

 

 

0.2

%

 

 

 

 

(3.2

)%

Organic Garden Segment Net Sales Reconciliation

 

GAAP to Non-GAAP Reconciliation

 

 

Three Months Ended June 29, 2024

 

Nine Months Ended June 29, 2024

 

 

Net sales
(GAAP)

 

Effect of
acquisitions
divestitures on
net sales

 

Net sales
organic

 

Net sales
(GAAP)

 

Effect of
acquisitions
divestitures on
net sales

 

Net sales
organic

 

 

(in millions)

Q3 FY 24

 

$

488.3

 

 

$

 

$

488.3

 

 

$

1,133.5

 

 

$

 

$

1,133.5

 

Q3 FY 23

 

 

520.0

 

 

 

13.0

 

 

507.0

 

 

 

1,165.6

 

 

 

44.4

 

 

1,121.2

 

$ increase (decrease)

 

$

(31.7

)

 

 

 

$

(18.7

)

 

$

(32.1

)

 

 

 

$

12.3

 

% increase (decrease)

 

 

(6.1

)%

 

 

 

 

(3.7

)%

 

 

(2.8

)%

 

 

 

 

1.1

%

Adjusted EBITDA Reconciliation

 

GAAP to Non-GAAP Reconciliation

 

 

Three Months Ended June 29, 2024

 

 

Pet

 

Garden

 

Corporate

 

Total

 

 

(in thousands)

Net income attributable to Central Garden Pet Company

 

$

 

$

 

$

 

 

$

79,724

 

Interest expense, net

 

 

 

 

 

 

 

 

 

10,216

 

Other income

 

 

 

 

 

 

 

 

 

(225

)

Income tax expense

 

 

 

 

 

 

 

 

 

25,468

 

Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

753

 

Income (loss) from operations

 

$

83,068

 

$

62,519

 

$

(29,651

)

 

$

115,936

 

Depreciation amortization

 

 

10,979

 

 

11,008

 

 

725

 

 

 

22,712

 

Noncash stock-based compensation

 

 

 

 

 

 

6,211

 

 

 

6,211

 

Facility closures business exit

(1)

 

 

 

11,115

 

 

 

 

 

11,115

 

Adjusted EBITDA

 

$

94,047

 

$

84,642

 

$

(22,715

)

 

$

155,974

 

Adjusted EBITDA Reconciliation

 

GAAP to Non-GAAP Reconciliation

 

 

Three Months Ended June 24, 2023

 

 

Pet

 

Garden

 

Corporate

 

Total

 

 

(in thousands)

Net income attributable to Central Garden Pet Company

 

$

 

$

 

$

 

 

$

83,126

 

Interest expense, net

 

 

 

 

 

 

 

 

 

13,134

 

Other income

 

 

 

 

 

 

 

 

 

(853

)

Income tax expense

 

 

 

 

 

 

 

 

 

27,000

 

Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

423

 

Income (loss) from operations

 

$

59,969

 

$

88,088

 

$

(25,227

)

 

$

122,830

 

Depreciation amortization

 

 

10,060

 

 

10,823

 

 

818

 

 

 

21,701

 

Noncash stock-based compensation

 

 

 

 

 

 

7,305

 

 

 

7,305

 

Facility closure

(3)

 

13,921

 

 

 

 

 

 

 

13,921

 

Adjusted EBITDA

 

$

83,950

 

$

98,911

 

$

(17,104

)

 

$

165,757

 

Adjusted EBITDA Reconciliation

 

GAAP to Non-GAAP Reconciliation

 

 

Nine Months Ended June 29, 2024

 

 

Pet

 

Garden

 

Corporate

 

Total

 

 

(in thousands)

Net income attributable to Central Garden Pet Company

 

$

 

$

 

$

 

 

$

142,141

 

Interest expense, net

 

 

 

 

 

 

 

 

 

31,396

 

Other income

 

 

 

 

 

 

 

 

 

(1,047

)

Income tax expense

 

 

 

 

 

 

 

 

 

43,733

 

Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

1,572

 

Income (loss) from operations

 

$

189,115

 

$

110,699

 

$

(82,019

)

 

$

217,795

 

Depreciation amortization

 

 

32,901

 

 

33,028

 

 

2,140

 

 

 

68,069

 

Noncash stock-based compensation

 

 

 

 

 

 

15,138

 

 

 

15,138

 

Facility closures business exit

(1) (2)

 

 

 

16,385

 

 

 

 

 

16,385

 

Adjusted EBITDA

 

$

222,016

 

$

160,112

 

$

(64,741

)

 

$

317,387

 

Adjusted EBITDA Reconciliation

 

GAAP to Non-GAAP Reconciliation

 

 

Nine Months Ended June 24, 2023

 

 

Pet

 

Garden

 

Corporate

 

Total

 

 

(in thousands)

Net income attributable to Central Garden Pet Company

 

$

 

$

 

$

 

 

$

122,808

 

Interest expense, net

 

 

 

 

 

 

 

 

 

41,600

 

Other income

 

 

 

 

 

 

 

 

 

(3,147

)

Income tax expense

 

 

 

 

 

 

 

 

 

39,446

 

Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

570

 

Income (loss) from operations

 

$

154,779

 

$

126,887

 

$

(80,389

)

 

$

201,277

 

Depreciation amortization

 

 

30,647

 

 

32,483

 

 

2,374

 

 

 

65,504

 

Noncash stock-based compensation

 

 

 

 

 

 

20,632

 

 

 

20,632

 

Facility closure

(3)

 

13,921

 

 

 

 

 

 

 

13,921

 

Adjusted EBITDA

 

$

199,347

 

$

159,370

 

$

(57,383

)

 

$

301,334

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240807439810/en/

Central Gar.c.a NV Stock

€29.80
-0.670%
Central Gar.c.a NV shows a slight decrease today, losing -€0.200 (-0.670%) compared to yesterday.

Like: 0
Share
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Legal notice

Comments